Legal & General Group Plc Has $268.91 Million Stake in Cardinal Health, Inc. (NYSE:CAH)

Legal & General Group Plc reduced its stake in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 14.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 2,273,694 shares of the company's stock after selling 375,315 shares during the period. Legal & General Group Plc owned 0.94% of Cardinal Health worth $268,910,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also made changes to their positions in the company. Cyrus J. Lawrence LLC acquired a new stake in Cardinal Health in the fourth quarter worth approximately $26,000. Promus Capital LLC bought a new stake in shares of Cardinal Health in the 4th quarter worth $30,000. Lee Danner & Bass Inc. acquired a new stake in shares of Cardinal Health in the fourth quarter valued at $35,000. Kentucky Trust Co bought a new position in Cardinal Health during the fourth quarter valued at about $41,000. Finally, HHM Wealth Advisors LLC grew its holdings in Cardinal Health by 57.6% during the fourth quarter. HHM Wealth Advisors LLC now owns 394 shares of the company's stock worth $47,000 after acquiring an additional 144 shares during the period. 87.17% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on the stock. Citigroup raised their price objective on shares of Cardinal Health from $120.00 to $129.00 and gave the company a "neutral" rating in a research report on Friday, January 10th. TD Cowen upgraded shares of Cardinal Health from a "hold" rating to a "buy" rating and raised their target price for the stock from $130.00 to $144.00 in a report on Wednesday, January 8th. Mizuho upped their price target on Cardinal Health from $142.00 to $150.00 and gave the company an "outperform" rating in a report on Monday, March 31st. Jefferies Financial Group raised Cardinal Health from a "hold" rating to a "buy" rating and raised their price objective for the stock from $140.00 to $150.00 in a research note on Wednesday, February 5th. Finally, Wells Fargo & Company boosted their target price on Cardinal Health from $135.00 to $136.00 and gave the stock an "equal weight" rating in a research report on Tuesday, February 4th. Four investment analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average target price of $140.86.

Remove Ads

Cardinal Health Trading Up 1.3 %

NYSE CAH traded up $1.65 during trading on Monday, reaching $133.42. 289,724 shares of the company's stock were exchanged, compared to its average volume of 2,174,743. The firm has a market capitalization of $32.23 billion, a PE ratio of 24.89, a P/E/G ratio of 1.49 and a beta of 0.61. Cardinal Health, Inc. has a fifty-two week low of $93.17 and a fifty-two week high of $139.50. The company's fifty day simple moving average is $129.33 and its 200-day simple moving average is $122.48.

Cardinal Health (NYSE:CAH - Get Free Report) last posted its quarterly earnings results on Thursday, January 30th. The company reported $1.93 EPS for the quarter, topping the consensus estimate of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. Equities analysts forecast that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be paid a $0.5056 dividend. The ex-dividend date of this dividend is Tuesday, April 1st. This represents a $2.02 annualized dividend and a dividend yield of 1.52%. Cardinal Health's payout ratio is 37.69%.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.